Cargando…
Using Monoclonal Antibody Therapies for Multiple Sclerosis: A Review
Monoclonal antibody therapies have secured an important role in the therapeutic landscape for the treatment of both relapsing and progressive forms of multiple sclerosis due to their potent efficacy, convenient dosing schedules, and well-defined side effect profiles. Each therapy has unique risks an...
Autores principales: | Elsbernd, Paul M, Carter, Jonathan L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255409/ https://www.ncbi.nlm.nih.gov/pubmed/34234409 http://dx.doi.org/10.2147/BTT.S267273 |
Ejemplares similares
-
Monoclonal Antibodies in Multiple Sclerosis: Present and Future
por: Voge, Natalia V., et al.
Publicado: (2019) -
Monoclonal Antibody Therapies for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
por: Kim, Woojun, et al.
Publicado: (2020) -
Monoclonal Antibodies in Preclinical EAE Models of Multiple Sclerosis: A Systematic Review
por: Schmitz, Katja, et al.
Publicado: (2017) -
Monoclonal Antibodies in Pregnancy and Breastfeeding in Patients with Multiple Sclerosis: A Review and an Updated Clinical Guide
por: Gklinos, Panagiotis, et al.
Publicado: (2023) -
Role of Monoclonal Antibody "Alemtuzumab" in the Treatment of Multiple Sclerosis
por: Nosher, Sadia, et al.
Publicado: (2021)